查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2030 年生理节律睡眠障碍的全球市场预测：按治疗类型、药物类型、年龄、配销通路、应用、最终用户和地区进行分析
市场调查报告书
商品编码
1383349

到 2030 年生理节律睡眠障碍的全球市场预测：按治疗类型、药物类型、年龄、配销通路、应用、最终用户和地区进行分析

Circadian Rhythm Seep Disorder Market Forecasts to 2030 - Global Analysis By Treatment Type, Drug Type, Age, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球生理节律睡眠障碍市场规模为 7.6187 亿美元，预计到 2030 年将达到 11.9174 亿美元，预测期内复合年增长率为 6.6%，预计将增长。

生理节律睡眠障碍是指昼夜节律（人体的内在手錶）出现异常的情况。与昼夜节律相关的睡眠障碍是由外在环境和中枢昼夜计时系统的变化所带来的。如果您难以按时入睡并且睡眠时间表被打乱，那么您通常患有生理节律睡眠障碍。生理节律睡眠障碍有多种类型，包括时差型、轮班工作障碍、提前睡眠相位障碍（ASPS）、延迟睡眠相位障碍（DSPD）和自由奔跑型。

根据睡眠心臟研究，有失眠或睡眠不足史的人罹患心血管疾病 (CVD) 的风险增加 29%。这些数字鼓励患有睡眠障碍的人寻求专业协助并增加市场需求。

改善识别和诊断

公共卫生配合措施、教育宣传活动以及透过数位平台普及资讯的力度加大，人们对生理节律睡眠障碍的认识不断提高。此外，诊断率的提高是患者和医疗保健提供者对 CRSD征兆和症状的认识提高的结果。随着诊断普及越来越普遍，越来越多的人正在寻求适当的治疗和管理方案，这正在推动市场扩张。

知识和意识不足

CRSD 市场的一个主要障碍是缺乏对与昼夜节律相关的睡眠障碍的知识和认识。公众和医疗专业人员可能都无法识别这些症状或将其误认为是其他疾病。此外，这种无知可能会导致诊断不足和治疗延迟，从而阻碍市场扩张。

研发进度

对睡眠障碍的昼夜节律、遗传学和神经生物学的持续研究使得针对 CRSD 各种亚型的新诊断设备、治疗性介入和药物的开发成为可能。此外，这项研究是改善患者治疗效果和更有效治疗的关键。

认识不足、误诊

公众和医疗保健相关人员对这些疾病的认识较低，对 CRSD 市场构成严重威胁。许多患有 CRSD 的人未被诊断或误诊，并且经常将他们的症状归咎于其他疾病。然而，知识不足阻碍了快速诊断和有效治疗。

COVID-19 的影响

生理节律睡眠障碍(CRSD) 市场受到 COVID-19大流行的各种影响。在大流行最严重的时候，患者就诊的减少、医疗保健服务的变化以及 COVID-19 病例的优先处理导致了 CRSD 诊断和治疗的延迟。睡眠诊所的暂时关闭及其运作限制影响了患者获得治疗的机会。此外，睡眠障碍的增加是由于生活方式的改变和大流行带来的心理压力。

灯箱细分市场预计将成为预测期内最大的细分市场

灯箱细分市场在生理节律睡眠障碍市场中占有最大份额。 CRSD 的重要非药物治疗之一是光疗，通常透过灯箱进行。对于轮班工作睡眠障碍和睡眠时相延迟障碍等疾病尤其如此。此外，灯箱产生的明亮人造光可以透过模拟阳光来帮助重置人的昼夜节律。灯箱在临床和家庭中广泛使用，可成功管理 CRSD 症状。光疗法广泛应用于CRSD的治疗计划中，并且由于其非侵入性且有效，在「光箱」类别中拥有很大的市场占有率。

健康中心和水疗中心部门预计在预测期内复合年增长率最高

生理节律睡眠障碍（CRSD）市场预计将在健康中心和水疗中心领域实现最高的复合年增长率。健康中心和水疗中心越来越多地在其菜单中添加睡眠健康服务，包括放鬆疗法和以 CRSD 为重点的治疗。此外，这些设置还提供针对睡眠障碍的全面治疗策略，强调放鬆和整体健康。随着人们越来越意识到睡眠与健康之间的联繫，他们开始转向健康中心和水疗中心寻求专业的治疗和疗法。

比例最高的地区：

北美（包括美国和加拿大）通常占据生理节律睡眠障碍（CRSD）的最大市场占有率份额。此外，该地区完善的医疗保健体系、出色的研发工作、睡眠障碍的高发病率以及人们对睡眠健康重要性的认识不断增强是这一优势的主要原因。该地区由于其富裕程度和睡眠障碍发病率高而成为 CRSD 市场的领导者，使其成为睡眠医学领域创新和发展的中心。

复合年增长率最高的地区：

生理节律睡眠障碍（CRSD）市场预计将成为亚太地区最高的复合年增长率。该地区的强劲增长得益于多种因素，包括睡眠卫生意识的提高、生活方式的变化导致 CRSD 发病率的增加以及医疗设施的发展。人们对整体健康和福祉的日益重视，加上亚太地区的经济扩张，正在推动对治疗睡眠障碍的创新方法的需求。此外，由于都市化、医疗保健支出增加和中阶扩大等因素，亚太地区 CRSD 市场正在经历快速成长。因此，该市场被定位为一个充满活力且快速扩张的细分市场，未来市场开拓备受期待。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球生理节律睡眠障碍市场：依治疗类型

  • 介绍
  • 治疗设备
  • 灯箱
  • 檯灯
  • 遮光板
  • 黎明模拟器
  • 诊断设备
  • 体动记录感测器
  • 手腕和手带体动记录仪
  • 穿戴式体动记录仪
  • 睡眠多项生理检查
  • 固定式睡眠多项生理检查测试装置
  • 便携式
  • 药品
  • 其他治疗类型

第6章全球生理节律睡眠障碍市场：依药物类型

  • 介绍
  • 苯二氮平类
  • 非苯二氮平类安眠药
  • Orexin受体拮抗
  • 褪黑激素受体促效剂
  • 莫达非尼
  • 他司美琼
  • 其他的

第7章全球生理节律睡眠障碍市场：依年龄分类

  • 介绍
  • 婴儿
  • 成人
  • 老年人

第8章全球生理节律睡眠障碍市场：按配销通路

  • 介绍
  • 企业销售
  • 零售

第9章全球生理节律睡眠障碍市场：依应用分类

  • 介绍
  • 睡眠时相延迟综合症
  • 晚期睡眠阶段综合症
  • 非24小时睡眠觉醒综合症
  • 不规则的睡眠/觉醒障碍
  • 轮班工作障碍
  • 时差
  • 其他用途

第10章全球生理节律睡眠障碍市场：依最终用户分类

  • 介绍
  • 居家医疗
  • 健康中心和水疗中心
  • 睡眠测试中心
  • 专科诊所
  • 其他最终用户

第11章全球生理节律睡眠障碍市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 中东和非洲其他地区

第12章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第13章公司简介

  • Carex Health
  • The Sunbox Company
  • Garmin Ltd.
  • BMC Medical Co., Ltd
  • Teva Pharmaceutical Industries Ltd.
  • Natus Medical Incorporated
  • Koninklijke Philips NV
  • Mylan NV
  • Vanda Pharmaceuticals Inc.
  • Neuraxpharm
  • Sunrise System
  • Beurer GmbH
  • Lanaform NV
  • Samarit Medical AG
  • Takeda Pharmaceutical Company
  • Northern Light Technologies
  • RedMed Inc.
  • ActiGraph, LLC
  • Verilux, Inc.
  • Akeda Pharmaceutical Company Limited
Product Code: SMRC24199

According to Stratistics MRC, the Global Circadian Rhythm Seep Disorder Market is accounted for $761.87 million in 2023 and is expected to reach $1191.74 million by 2030 growing at a CAGR of 6.6% during the forecast period. The term circadian rhythm sleep disorders (CRSDs) refers to conditions where the body's internal clock, the circadian rhythms, are abnormal. Sleep disorders related to the circadian rhythm are brought on by changes in the external environment and the central circadian timekeeping system. When a person struggles to go to sleep at a regular time and interferes with their sleep schedule, they usually have circadian rhythm sleep disorders. And, there are various types of circadian rhythm sleep disorders, including jet lag, shift work disorder, advanced sleep phase disorder (ASPS), delayed sleep phase disorder (DSPD), and the free-running type.

According to a sleep heart study, those who had a history of insomnia or poor sleep had a 29 % increased risk of cardiovascular disease (CVD). These kinds of figures encourage those suffering from sleep disorders to seek expert assistance, hence raising the market's demand.

Market Dynamics:

Driver:

Increasing awareness and diagnosis

Increased public health efforts, education campaigns, and the spread of information via digital platforms are all responsible for the rising awareness of circadian rhythm sleep disorders. Additionally, rising diagnosis rates are a result of patients and medical professionals' increased awareness of the telltale signs and symptoms of CRSDs. Growing numbers of people are seeking suitable treatment and management options as diagnosis becomes more widely available, which propels market expansion.

Restraint:

Inadequate knowledge and awareness

A major barrier to the CRSD market is the lack of knowledge and awareness regarding sleep disorders related to the circadian rhythm. Both the general public and medical professionals might not be aware of the symptoms or might mistake them for other illnesses. Moreover, this ignorance may result in under diagnosis and postponed treatment, impeding the expansion of the market.

Opportunity:

Advances in research and development

The development of novel diagnostic instruments, therapeutic interventions, and pharmaceuticals specifically designed for various subtypes of CRSDs is made possible by ongoing research into circadian rhythms, genetics, and the neurobiology of sleep disorders. Additionally, this study holds the key to improved patient outcomes and more potent treatments.

Threat:

Insufficient knowledge and misdiagnosis

The low awareness of these disorders among the general public and medical professionals poses a serious threat to the CRSD market. Many people with CRSDs go undiagnosed or are misdiagnosed, and they frequently blame their symptoms on other medical conditions. However, inadequate knowledge impedes prompt diagnosis and efficient therapy.

COVID-19 Impact:

The Circadian Rhythm Sleep Disorder (CRSD) market was impacted by the COVID-19 pandemic in a number of ways. Delays in diagnosing and treating CRSDs occurred during the height of the pandemic due to decreased patient visits, changes in healthcare services, and the prioritization of COVID-19 cases. Patient access to care was impacted by the temporary closure of sleep clinics and the implementation of restrictions on their operations. Additionally, a rise in sleep disorders was attributed to changes in lifestyle and psychological stress brought on by the pandemic.

The Light Box segment is expected to be the largest during the forecast period

In the market for circadian rhythm sleep disorders, the Light Box segment has the largest share. One important non-pharmacological treatment for CRSDs is light therapy, which is frequently given through light boxes. This is especially true for disorders like shift work sleeps disorder and delayed sleep phase disorder. Moreover, bright artificial light produced by light boxes can help reset a person's circadian rhythms by simulating sunlight. They are extensively utilized to successfully manage CRSD symptoms in both clinical and domestic contexts. Because light therapy is widely used in CRSD treatment plans and is both non-invasive and effective, it has a significant market share in the "Light Box" category.

The Wellness Centers & Spa segment is expected to have the highest CAGR during the forecast period

The Circadian Rhythm Sleep Disorder (CRSD) market is expected to grow at the highest CAGR in the Wellness Centers & Spa segment. A growing number of wellness centers and spas are adding sleep health services to their menus, such as relaxation therapies and CRSD-focused treatments. Additionally, these environments offer a comprehensive strategy for treating sleep disorders, emphasizing relaxation and general well-being. People are going to wellness centers and spas for specialized treatments and therapies as awareness of the link between sleep and wellbeing increases.

Region with largest share:

In terms of market share for Circadian Rhythm Sleep Disorder (CRSD), North America, which includes the United States and Canada, usually has the largest share. Moreover, the region's established healthcare system, prodigious R&D endeavours, high incidence of sleep disorders, and growing consciousness regarding the importance of sleep health are the main causes of this dominance. Due to its high level of affluence and high rate of sleep disorders, the region leads the CRSD market and serves as a hub for innovations and developments in the field of sleep medicine.

Region with highest CAGR:

In the Circadian Rhythm Sleep Disorder (CRSD) market, the Asia-Pacific region is projected to have the highest CAGR. The region's strong growth is ascribed to various factors, including growing consciousness regarding sleep hygiene, the increasing occurrence of CRSDs as a result of evolving lifestyles, and the development of healthcare facilities. A greater emphasis on general health and well-being, coupled with the expansion of economies in the Asia-Pacific region, is driving demand for creative approaches to sleep disorders. Additionally, the Asia-Pacific CRSD market has experienced rapid growth due to factors such as urbanization, rising healthcare expenditures, and the region's expanding middle class. This has positioned the market as a dynamic and rapidly expanding segment with significant potential for future development.

Key players in the market

Some of the key players in Circadian Rhythm Seep Disorder market include: Carex Health, The Sunbox Company, Garmin Ltd., BMC Medical Co., Ltd, Teva Pharmaceutical Industries Ltd., Natus Medical Incorporated , Koninklijke Philips N.V., Mylan N.V., Vanda Pharmaceuticals Inc., Neuraxpharm, Sunrise System , Beurer GmbH, Lanaform N.V., Samarit Medical AG, Takeda Pharmaceutical Company, Northern Light Technologies , RedMed Inc. , ActiGraph, LLC, Verilux, Inc. and Akeda Pharmaceutical Company Limited .

Key Developments:

In August 2023, Garmin Ltd., announced it has entered into a definitive agreement to acquire JL Audio, a privately-held U.S. company that designs and manufactures audio solutions for marine, aftermarket automotive, powersports, home and RV customers.

In July 2023, Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and Alvotech, a global biotech company specializing in the development and manufacture of biosimilars, expanded their existing strategic partnership agreement. Teva will also acquire subordinated convertible bonds to be issued by Alvotech.

In December 2022, Natus Medical announced that it entered into a definitive agreement to acquire neurophysiology solution provider Micromed. Middleton, Wisconsin-based Natus expects the transaction to close in early 2023. The company elected not to disclose the financial terms of the deal. It marks the first transaction made by the company since its $1.2 billion acquisition by the ArchiMed group in July.

Treatment Types Covered:

  • Therapeutic Devices
  • Light Box
  • Desk Lamps
  • Light Visor
  • Dawn Simulator
  • Diagnostic Devices
  • Actigraphy Sensors
  • Wrist and Hand Band Actigraphy Devices
  • Wearable Actigraphy Devices
  • Polysomnography Devices
  • Fixed Polysomnography Devices
  • Portable
  • Medications
  • Other Treatment Types

Drug Types Covered:

  • Benzodiazepines
  • Non benzodiazepine Hypnotics
  • Orexin Receptor Antagonists
  • Melatonin Receptor Agonist
  • Modafinil
  • Tasimelteon
  • Other Drug Types

Ages Covered:

  • Children
  • Adults
  • Elders

Distribution Channels Covered:

  • Institutional Sales
  • Retail Sales

Applications Covered:

  • Delayed Sleep Phase Syndrome
  • Advanced Sleep Phase Syndrome
  • Non-24-h sleep-wake syndrome
  • Irregular Sleep-Wake Disorder
  • Shift Work Disorder
  • Jet Lag
  • Other Applications

End Users Covered:

  • Home Care Settings
  • Wellness Centers & Spa
  • Sleep Testing Centers
  • Specialty Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Circadian Rhythm Seep Disorder Market, By Treatment Type

  • 5.1 Introduction
  • 5.2 Therapeutic Devices
  • 5.3 Light Box
  • 5.4 Desk Lamps
  • 5.5 Light Visor
  • 5.6 Dawn Simulator
  • 5.7 Diagnostic Devices
  • 5.8 Actigraphy Sensors
  • 5.9 Wrist and Hand Band Actigraphy Devices
  • 5.10 Wearable Actigraphy Devices
  • 5.11 Polysomnography Devices
  • 5.12 Fixed Polysomnography Devices
  • 5.13 Portable
  • 5.14 Medications
  • 5.15 Other Treatment Types

6 Global Circadian Rhythm Seep Disorder Market, By Drug Type

  • 6.1 Introduction
  • 6.2 Benzodiazepines
  • 6.3 Non benzodiazepine Hypnotics
  • 6.4 Orexin Receptor Antagonists
  • 6.5 Melatonin Receptor Agonist
  • 6.6 Modafinil
  • 6.7 Tasimelteon
  • 6.8 Other Drug Types

7 Global Circadian Rhythm Seep Disorder Market, By Age

  • 7.1 Introduction
  • 7.2 Children
  • 7.3 Adults
  • 7.4 Elders

8 Global Circadian Rhythm Seep Disorder Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Institutional Sales
  • 8.3 Retail Sales

9 Global Circadian Rhythm Seep Disorder Market, By Application

  • 9.1 Introduction
  • 9.2 Delayed Sleep Phase Syndrome
  • 9.3 Advanced Sleep Phase Syndrome
  • 9.4 Non-24-h sleep-wake syndrome
  • 9.5 Irregular Sleep-Wake Disorder
  • 9.6 Shift Work Disorder
  • 9.7 Jet Lag
  • 9.8 Other Applications

10 Global Circadian Rhythm Seep Disorder Market, By End User

  • 10.1 Introduction
  • 10.2 Home Care Settings
  • 10.3 Wellness Centers & Spa
  • 10.4 Sleep Testing Centers
  • 10.5 Specialty Clinics
  • 10.6 Other End Users

11 Global Circadian Rhythm Seep Disorder Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Carex Health
  • 13.2 The Sunbox Company
  • 13.3 Garmin Ltd.
  • 13.4 BMC Medical Co., Ltd
  • 13.5 Teva Pharmaceutical Industries Ltd.
  • 13.6 Natus Medical Incorporated
  • 13.7 Koninklijke Philips N.V.
  • 13.8 Mylan N.V.
  • 13.9 Vanda Pharmaceuticals Inc.
  • 13.10 Neuraxpharm
  • 13.11 Sunrise System
  • 13.12 Beurer GmbH
  • 13.13 Lanaform N.V.
  • 13.14 Samarit Medical AG
  • 13.15 Takeda Pharmaceutical Company
  • 13.16 Northern Light Technologies
  • 13.17 RedMed Inc.
  • 13.18 ActiGraph, LLC
  • 13.19 Verilux, Inc.
  • 13.20 Akeda Pharmaceutical Company Limited

List of Tables

  • Table 1 Global Circadian Rhythm Seep Disorder Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Circadian Rhythm Seep Disorder Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 3 Global Circadian Rhythm Seep Disorder Market Outlook, By Therapeutic Devices (2021-2030) ($MN)
  • Table 4 Global Circadian Rhythm Seep Disorder Market Outlook, By Light Box (2021-2030) ($MN)
  • Table 5 Global Circadian Rhythm Seep Disorder Market Outlook, By Desk Lamps (2021-2030) ($MN)
  • Table 6 Global Circadian Rhythm Seep Disorder Market Outlook, By Light Visor (2021-2030) ($MN)
  • Table 7 Global Circadian Rhythm Seep Disorder Market Outlook, By Dawn Simulator (2021-2030) ($MN)
  • Table 8 Global Circadian Rhythm Seep Disorder Market Outlook, By Diagnostic Devices (2021-2030) ($MN)
  • Table 9 Global Circadian Rhythm Seep Disorder Market Outlook, By Actigraphy Sensors (2021-2030) ($MN)
  • Table 10 Global Circadian Rhythm Seep Disorder Market Outlook, By Wrist and Hand Band Actigraphy Devices (2021-2030) ($MN)
  • Table 11 Global Circadian Rhythm Seep Disorder Market Outlook, By Wearable Actigraphy Devices (2021-2030) ($MN)
  • Table 12 Global Circadian Rhythm Seep Disorder Market Outlook, By Polysomnography Devices (2021-2030) ($MN)
  • Table 13 Global Circadian Rhythm Seep Disorder Market Outlook, By Fixed Polysomnography Devices (2021-2030) ($MN)
  • Table 14 Global Circadian Rhythm Seep Disorder Market Outlook, By Portable (2021-2030) ($MN)
  • Table 15 Global Circadian Rhythm Seep Disorder Market Outlook, By Medications (2021-2030) ($MN)
  • Table 16 Global Circadian Rhythm Seep Disorder Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 17 Global Circadian Rhythm Seep Disorder Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 18 Global Circadian Rhythm Seep Disorder Market Outlook, By Benzodiazepines (2021-2030) ($MN)
  • Table 19 Global Circadian Rhythm Seep Disorder Market Outlook, By Non benzodiazepine Hypnotics (2021-2030) ($MN)
  • Table 20 Global Circadian Rhythm Seep Disorder Market Outlook, By Orexin Receptor Antagonists (2021-2030) ($MN)
  • Table 21 Global Circadian Rhythm Seep Disorder Market Outlook, By Melatonin Receptor Agonist (2021-2030) ($MN)
  • Table 22 Global Circadian Rhythm Seep Disorder Market Outlook, By Modafinil (2021-2030) ($MN)
  • Table 23 Global Circadian Rhythm Seep Disorder Market Outlook, By Tasimelteon (2021-2030) ($MN)
  • Table 24 Global Circadian Rhythm Seep Disorder Market Outlook, By Other Drug Types (2021-2030) ($MN)
  • Table 25 Global Circadian Rhythm Seep Disorder Market Outlook, By Age (2021-2030) ($MN)
  • Table 26 Global Circadian Rhythm Seep Disorder Market Outlook, By Children (2021-2030) ($MN)
  • Table 27 Global Circadian Rhythm Seep Disorder Market Outlook, By Adults (2021-2030) ($MN)
  • Table 28 Global Circadian Rhythm Seep Disorder Market Outlook, By Elders (2021-2030) ($MN)
  • Table 29 Global Circadian Rhythm Seep Disorder Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 30 Global Circadian Rhythm Seep Disorder Market Outlook, By Institutional Sales (2021-2030) ($MN)
  • Table 31 Global Circadian Rhythm Seep Disorder Market Outlook, By Retail Sales (2021-2030) ($MN)
  • Table 32 Global Circadian Rhythm Seep Disorder Market Outlook, By Application (2021-2030) ($MN)
  • Table 33 Global Circadian Rhythm Seep Disorder Market Outlook, By Delayed Sleep Phase Syndrome (2021-2030) ($MN)
  • Table 34 Global Circadian Rhythm Seep Disorder Market Outlook, By Advanced Sleep Phase Syndrome (2021-2030) ($MN)
  • Table 35 Global Circadian Rhythm Seep Disorder Market Outlook, By Non-24-h sleep-wake syndrome (2021-2030) ($MN)
  • Table 36 Global Circadian Rhythm Seep Disorder Market Outlook, By Irregular Sleep-Wake Disorder (2021-2030) ($MN)
  • Table 37 Global Circadian Rhythm Seep Disorder Market Outlook, By Shift Work Disorder (2021-2030) ($MN)
  • Table 38 Global Circadian Rhythm Seep Disorder Market Outlook, By Jet Lag (2021-2030) ($MN)
  • Table 39 Global Circadian Rhythm Seep Disorder Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 40 Global Circadian Rhythm Seep Disorder Market Outlook, By End User (2021-2030) ($MN)
  • Table 41 Global Circadian Rhythm Seep Disorder Market Outlook, By Home Care Settings (2021-2030) ($MN)
  • Table 42 Global Circadian Rhythm Seep Disorder Market Outlook, By Wellness Centers & Spa (2021-2030) ($MN)
  • Table 43 Global Circadian Rhythm Seep Disorder Market Outlook, By Sleep Testing Centers (2021-2030) ($MN)
  • Table 44 Global Circadian Rhythm Seep Disorder Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 45 Global Circadian Rhythm Seep Disorder Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.